Brain, Vol. 125, No. 8, 1887-1895,
August 2002
© 2002 Guarantors of Brain
Phenotypic variants of autoimmune peripheral nerve hyperexcitability
1 Neuroimmunology Group, University Department of Neurological Science, Walton Centre, Liverpool, 2 University Department of Clinical Neurology, Institute of Molecular Medicine, Oxford, 3 Department of Neurophysiology, King’s College Hospital, London, UK
Correspondence to: P. Maddison, Neurology Department, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK E-mail: paul{at}piglet2.demon.co.uk
Clinicians use many terms including undulating myokymia, neuromyotonia, Isaacs’ syndrome and Cramp–Fasciculation Syndrome to describe the motor manifestations of generalized peripheral nerve hyperexcitability (PNH). Our previous findings in a selected group of patients with undulating myokymia or neuromyotonia, and EMG doublet or multiplet (‘myokymic’) motor unit discharges, indicated that an autoantibody-mediated potassium channelopathy was likely to be the cause of their disorder. This prompted us to search for a common pathogenesis in a wider spectrum of PNH syndromes. We studied the clinical, autoimmune and electrophysiological features of 60 patients presenting with acquired PNH. Patients were grouped according to an EMG criterion: the presence (group A, n = 42) or absence (group B, n = 18) of doublet or multiplet myokymic motor unit discharges. The average ages of onset in the two groups were 45 and 48 years respectively. The relative frequency and topography of the clinical features were similar in both groups. Serum voltage-gated potassium channel (VGKC) antibodies were detected using a 125I-
-dendrotoxin immunoprecipitation assay in 38% of group A and in 28% of group B. Autoimmune disease and other autoantibodies were present in both groups more frequently than would be expected by chance (59 and 28%, respectively)—particularly myasthenia gravis and acetylcholine receptor (AChR) antibodies. The neurological disorder in both groups could occur as a paraneoplastic condition. Thymoma was detected in 19 and 11%, respectively, and lung cancer in 10 and 6%, respectively. An axonal neuropathy was present in six (14%) of group A and in one (6%) of group B patients. Thus, despite the discrete EMG distinction, both groups share clinical features often associated with autoimmune-related diseases, which can occur as paraneoplastic disorders and, importantly, have an increased frequency of VGKC antibodies. We conclude that autoimmunity, and specifically VGKC antibodies in many cases, are strongly implicated in the pathogenesis of both groups, and that the EMG features reflect quantitative rather than qualitative differences between the diverse clinical syndromes. These findings also have relevance for disease management. A classification is proposed that distinguishes immune-mediated PNH (irrespective of whether VGKC antibodies are detectable by standard assays) from non-immune forms of PNH that include toxins, anterior horn cell degeneration in motor neurone disease and genetic disorders.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. B. Park, C. S.-Y. Lin, A. V. Krishnan, D. Goldstein, M. L. Friedlander, and M. C. Kiernan Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy Brain, October 1, 2009; 132(10): 2712 - 2723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ng, J. Howells, J. D. Pollard, and D. Burke Up-regulation of slow K+ channels in peripheral motor axons: a transcriptional channelopathy in multiple sclerosis Brain, November 1, 2008; 131(11): 3062 - 3071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A T Toosy, S E Burbridge, M Pitkanen, A S Loyal, N Akanuma, H Laing, M D Kopelman, and T C Andrews Functional imaging correlates of fronto-temporal dysfunction in Morvan's syndrome J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 734 - 735. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Maljevic, T. V. Wuttke, and H. Lerche Nervous system KV7 disorders: breakdown of a subthreshold brake J. Physiol., April 1, 2008; 586(7): 1791 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Wuttke, K. Jurkat-Rott, W. Paulus, M. Garncarek, F. Lehmann-Horn, and H. Lerche Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations Neurology, November 27, 2007; 69(22): 2045 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. McKeon, M. Marnane, M. O'Connell, J. P. Stack, P. J. Kelly, and T. Lynch Potassium Channel Antibody Associated Encephalopathy Presenting With a Frontotemporal Dementia like Syndrome Arch Neurol, October 1, 2007; 64(10): 1528 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kleopa, L. B. Elman, B. Lang, A. Vincent, and S. S. Scherer Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations Brain, June 1, 2006; 129(6): 1570 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M R Turner, A Madkhana, G C Ebers, L Clover, A Vincent, G McGavin, P Sarrigiannis, R Kennett, and D A Warrell Wasp sting induced autoimmune neuromyotonia J. Neurol. Neurosurg. Psychiatry, May 1, 2006; 77(5): 704 - 705. [Full Text] [PDF]
|
|
|
|
|
|
S. Herskovitz, H. Song, D. Cozien, and S. Scelsa Sensory symptoms in acquired neuromyotonia Neurology, October 25, 2005; 65(8): 1330 - 1331. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gomez-Choco, J. Valls-Sole, J. M. Grau, and F. Graus Episodic hyperhidrosis as the only clinical manifestation of neuromyotonia Neurology, October 25, 2005; 65(8): 1331 - 1332. [Full Text] [PDF]
|
|
|
|
|
|
C. Antozzi, C. Frassoni, A. Vincent, M. C. Regondi, F. Andreetta, P. Bernasconi, C. Ciano, T. Chang, F. Cornelio, R. Spreafico, et al. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia Neurology, April 12, 2005; 64(7): 1290 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-D. Sperfeld, C. O. Hanemann, A. C. Ludolph, and J. Kassubek Laryngospasm: An underdiagnosed symptom of X-linked spinobulbar muscular atrophy Neurology, February 22, 2005; 64(4): 753 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D A Cottrell, K J Blackmore, P R W Fawcett, D Birchall, A Vincent, S Barnard, and T J Walls Sub-acute presentation of Morvan's syndrome after thymectomy J. Neurol. Neurosurg. Psychiatry, October 1, 2004; 75(10): 1504 - 1505. [Full Text] [PDF]
|
|
|
|
|
|
D. Beeson Autoantibodies in the CNS: Encephalopathy and potassium channelopathy Neurology, April 13, 2004; 62(7): 1040 - 1041. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Thieben, V. A. Lennon, B. F. Boeve, A. J. Aksamit, M. Keegan, and S. Vernino Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody Neurology, April 13, 2004; 62(7): 1177 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vincent, C. Buckley, J. M. Schott, I. Baker, B.-K. Dewar, N. Detert, L. Clover, A. Parkinson, C. G. Bien, S. Omer, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis Brain, March 1, 2004; 127(3): 701 - 712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Darnell and J. B. Posner Paraneoplastic Syndromes Involving the Nervous System N. Engl. J. Med., October 16, 2003; 349(16): 1543 - 1554. [Full Text] [PDF]
|
|